Top 10 Funds That Aren't in Your 401(k)
Kevin Baker
08/19/08 - 03:05 PM EDT
The 10 best performing equity mutual funds in July are not likely to be offerings in your 401k plan. Most companies limit the number of fund choices available to employees by excluding most narrowly focused sector funds.
If you find it impossible to adequately diversify the investments within your 401k, remember that the goal is to diversify your whole retirement nest egg. So, if you opt for broad-based growth funds in the 401k, then as a small part of an overall diversified retirement portfolio riskier sector funds may be considered for your Rollover IRA, Roth IRA or regular individual retirement accounts.
A sector rotation strategy attempts to find the few sectors outperforming the overall market and shifts money into funds holding those companies. Five of the 10 best performing funds in July were targeting the biotechnology sector.
Exceeding all other equity mutual funds, the 150% leveraged
ProFunds Biotechnology UltraSector ProFund(BIPIX) returned 28.35% in July. As stock investors snap up
Gilead Sciences(GILD),
Amgen(AMGN),
Genentech(DNA),
Celgene(CELG) and
Biogen Idec(BIIB) this fund could do well.
Banking funds like the
ProFunds Banks UltraSector ProFund(BKPIX), coming in at second place, bottomed and bounced back in July. But, I don't think
Bank of America(BAC),
JPMorgan Chase(JPM),
Citigroup(C) and
Wells Fargo(WFC) will be out of the woods until real estate prices head north again.
With the plethora of inverse funds available today it is easier than ever to profit from a bear market in individual sectors. The remaining four funds gained by shorting Latin America, oil & gas, emerging markets, and precious metals.
| 10 Best Performing Equity Mutual Funds in July |
| Fund (Ticker) Rating |
Objective |
1 Month Total Return % |
3 Month Total Return % |
| ProFunds-Biotech Ultra Sector Inv (BIPIX) B- |
Sector - Health/Biotechnology |
28.35 |
35.34 |
| ProFunds-Bank UltraSector Inv (BKPIX) E- |
Sector - Financial Services |
26.19 |
-26.33 |
| Allianz RCM Biotechnology A (RABTX) D- |
Sector - Health/Biotechnology |
22.07 |
24.80 |
| Rydex Series-Biotechnology A (RYBOX) C |
Sector - Health/Biotechnology |
19.03 |
20.40 |
| ProFunds-Ultra Sh Latin America Inv (UFPIX) U |
Non-US Equity |
18.87 |
13.31 |
| ProFunds Short Oil & Gas Inv (SNPIX) U |
Sector - Energy/Natural Res |
15.37 |
7.51 |
| Profunds-Ultra Sh Emer Mkt Inv (UVPIX) U |
Emerging Market Equity |
15.29 |
23.98 |
| Fidelity Select Biotech Port (FBIOX) C |
Sector - Health/Biotechnology |
13.71 |
18.87 |
| ProFunds Short Precious Metals Inv (SPPIX) U |
Sector - Precious Metals |
13.39 |
-0.86 |
| Franklin Biotechnology Discovery A (FBDIX) C- |
Sector - Health/Biotechnology |
13.37 |
19.38 |
| Source: TheStreet.com Ratings |
For an explanation of our ratings,
click here.